Retinal Nerve Fiber Layer Damage as Assessed by Optical Coherence Tomography in Eyes with a Visual Field Defect Detected
by Frequency Doubling Technology Perimetry but Not by Standard Automated Perimetry
To access this article, please choose from the options below
Manuscript no. 2006-348.
Disclosure: research support from Carl Zeiss Meditec (LMZ, PAS, RNW), Heidelberg Engineering (LMZ, RNW), Welch-Allyn (PAS), and Haag-Streit (PAS). Honoraria from Heidelberg Engineering (LMZ, RNW) and Carl Zeiss Meditec (RNW).
Supported by the National Institutes of Health, Bethesda, Maryland (grant nos. EY11008 [LMZ], EY08208 [PAS]). Participant retention incentive grants in the form of glaucoma medication at no cost: Alcon Laboratories, Inc., Fort Worth, Texas; Allergan, Irvine, California; Pfizer, Inc., New York, New York; and Santen, Inc., Napa, California.
PII: S0161-6420(06)01313-3
doi:10.1016/j.ophtha.2006.09.015
© 2007 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

